In our first blog, we reviewed the defining themes of 2025 and explored macro and policy issues shaping the year ahead
On average, volunteers in the retatrutide clinical trial who received the study drug rather than a placebo lost an average of 70.3 pounds over about a year-and-a-half, with more than 45% of participants losing more than 30% of their body weight
In this study, we found that BPC-157 is effective in the very low dose range and accelerates wound healing and that the wound repair process, which involves steps that include inflammation, collagen deposition, angiogenesis, development of granulation tissue, and the repair of epithelium, in bFGF- or BPC-157-treated groups was better than that in the model control group
Severe gastroesophageal reflux with esophagitis
These tree-like nanostructures improve peptide penetration through cell membranes
Research at Washington University School of Medicine found that NNMT inhibition with small-molecule inhibitors restored NAD+ levels by 6080% and increased energy expenditure by 1114% in diet-induced obesity models
